{
    "cancelStatus": "0",
    "cancelDate": null,
    "cancelReason": [],
    "licid": "06021368",
    "validDate": "2025-07-28 00:00:00.000",
    "issueDate": "2010-07-28 00:00:00.000",
    "licKind": "09",
    "oldLicid": null,
    "certNo": "DHA00602136800",
    "prodNameC": "貝克曼庫爾特網狀紅血球品管劑",
    "prodNameE": "BECKMAN COULTER Retic-X Cell Control",
    "indicationsName": [],
    "does": null,
    "packageUnit": [],
    "medMCode": null,
    "maMedCode": null,
    "medDCode": null,
    "ingredientsDesc": [
        "Retic-X Cell Control consists of treated, stabilized human erythrocytes in an isotonic medium. Retic-X Cell Control also contains a stabilized, reticulocyte-like component."
    ],
    "restraintItemsCode": [
        "R02"
    ],
    "applicantName": "美商貝克曼庫爾特有限公司台灣分公司",
    "applicantAddr": "台北市大安區敦化南路二段216號8樓",
    "medClass": "2",
    "efficacy": "Retic-X網狀紅血球品管劑配合使用指定的庫爾特試劑，可根據表列的期望目標值來監測庫爾特血液分析系統的效能。 ",
    "mdFormat": "#628028",
    "productAnnotation": null,
    "mdKind": [
        {
            "mdKindMCode": "B",
            "mdKindMCodeName": "B 血液學及病理學裝置",
            "mdKindDCode": "B.8625",
            "mdKindDCodeName": "B.8625 血液學品質管制混合物",
            "checkChange": "Y"
        }
    ],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "BECKMAN COULTER INC.",
            "factoryAddr": "740 W. 83RD STREET, HIALEAH, FL 33014, U.S.A.",
            "factoryCompanyAddr": null,
            "countryCode": "US",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "MUS1066000",
            "factoryInfo": "1",
            "qsd": "QSD4068"
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": "Retic-X Cell Control consists of treated, stabilized human erythrocytes in an isotonic medium. Retic-X Cell Control also contains a stabilized, reticulocyte-like component.",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [
        {
            "fileType": "2",
            "fileName": "060213680001___20100914.pdf",
            "fileStreamId": "2340F7ED-A545-4A42-8413-E1FD06077855"
        },
        {
            "fileType": "1",
            "fileName": "060213680001___20100914.pdf",
            "fileStreamId": "BCA61E52-B5BE-4E80-A316-AF859E098CAB"
        }
    ],
    "changeDtoList": [],
    "atcList": [],
    "licBaseId": "B4C9B7DC-8B9D-4E7D-9EA2-31FED336A39C"
}